This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kumar H, Kawai T, Akira S . Pathogen recognition by the innate immune system. Int Rev Immunol 2011; 30: 16–34.
Liew FY, Xu D, Brint EK, O'Neil LA . Negative regulation of Toll-like receptor-mediated immune responses. Nat Rev Immunol 2005; 5: 446–455.
Yuk JM, Shin DM, Lee HM, Kim JJ, Kim SW, Jin HS et al. The orphan nuclear receptor SHP acts as a negative regulator in inflammatory signaling triggered by Toll-like receptors. Nat Immunol 2011; 12: 742–751.
Liu XM, Peyton KJ, Shebib AR, Wang H, Korthuis RJ, Durante W . Activation of AMPK stimulates heme oxygenase-1 gene expression and human endothelial cell survival. Am J Physiol Heart Circ Physiol 2011; 300: H84–H93.
Paine A, Eiz-Vesper B, Blasczyk R, Immenschuh S . Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem Pharmacol 2010; 80: 1895–1903.
Zhang BB, Zhou G, Li C . AMPK: an emerging drug target for diabetes and the metabolic syndrome. Cell Metab 2009; 9: 407–416.
Koenner AC, Bruening JC . Toll-like receptors: linking inflammation to metabolism. Trends Endocrinol Metabol 2010; 22: 16–23.
Salminen A, Hyttinen JM, Kaarmiranta KJ . AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan. Mol Med 2011; 89: 667–676.
Canto C, Auwerx J . AMP-activated protein kinase and its downstream transcriptional pathways. Cell Mol Life Sci 2010; 67: 3407–3423.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Chung, HT. SHP gains citizenship of the AMPK kingdom. Cell Mol Immunol 8, 450–452 (2011). https://doi.org/10.1038/cmi.2011.39
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cmi.2011.39